Goldman Sachs Reveals 7.2% Stake in Translational Development Acquisition Corp.
The Goldman Sachs Group has disclosed its stake in Translational Development Acquisition Corp. (TDAC), reporting beneficial ownership of 1,056,879 Class A ordinary shares.
This represents a 7.2% stake in the company and is attributed to both The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC.
The entities report shared voting power and dispositive power over these shares, indicating that they have joint control over their TDAC holdings.